SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001274737-22-000070
Filing Date
2022-11-14
Accepted
2022-11-14 16:08:05
Documents
14
Period of Report
2022-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K exdx-20221114.htm   iXBRL 8-K 45502
2 EX-99.1 exagen3q22earningspressrel.htm EX-99.1 83090
6 image_0.jpg GRAPHIC 29843
  Complete submission text file 0001274737-22-000070.txt   322247

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT exdx-20221114.xsd EX-101.SCH 1896
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT exdx-20221114_lab.xml EX-101.LAB 24831
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT exdx-20221114_pre.xml EX-101.PRE 13039
8 EXTRACTED XBRL INSTANCE DOCUMENT exdx-20221114_htm.xml XML 11232
Mailing Address 1261 LIBERTY WAY VISTA CA 92081
Business Address 1261 LIBERTY WAY VISTA CA 92081 (760) 560-1501
EXAGEN INC. (Filer) CIK: 0001274737 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39049 | Film No.: 221385192
SIC: 8071 Services-Medical Laboratories